Posters highlighting work or activities to improve adult and influenza immunization will be presented during the 2020 NAIIS Summit Meeting in Atlanta, Georgia. Presenting a poster at the annual meeting provides an effective means to share the results of presenters’ efforts, stimulates discussion with other attendees, and offers an opportunity for a more personal exchange of ideas.
Abstract Submission Timeline
November 1, 2019 — Website open for abstract submissions
March 15, 2020 — Submission site closed while abstract review is conducted
April 1, 2020 — Corresponding author(s) notified of decision
May 18, 2020 — Poster presentation during annual meeting in Atlanta, GA
Poster session will take place during the lunch hour on May 18th.
Posters will remain in place until [TBD].
Poster Abstract Submission FAQs
What topics are acceptable for abstracts?
Abstracts should describe results of work and/or activities that improve adult or influenza immunization, such as implementation of the adult immunization practice standards, utilization of electronic medical records (EMR) or immunization information systems (IIS), addressing policy or other barriers to immunization, addressing quality measures, economics of influenza or adult vaccine-preventable diseases or vaccination services, assessing or improving the awareness and uptake of influenza or adult vaccines, or innovative collaborations to improve immunizations.
(A specific listing of topics is available on the 2020 Poster Abstract Submission Form.)
Are there any limitations on what may be discussed on a poster?
Abstracts and posters marketing or promoting a specific commercial product or service will not be accepted.
What is the acceptable length for an abstract?
Abstracts must be 150 words or less.
Can an abstract with results that will not be available until the time of the meeting be reviewed?
Yes. In your abstract, please describe the information/data you are planning to present and the anticipated timing of availability.
If I submit a poster abstract and it is selected for presentation at the Summit Annual Meeting, will it affect my ability to be considered for one of the Summit’s 2020 Immunization Excellence Awards?
No. The poster process and the 2020 Immunization Excellence Awards selection process are completely separate.
What size is the poster display area?
A standard 8′ wide by 4′ tall area is available for each poster.
Who will be reviewing the abstracts?
The Abstract Review Committee will consist of representatives from the NAIIS lead organizations (National Vaccine Program Office, Centers for Disease Control and Prevention, and Immunization Action Coalition) and the National Adult Immunization Coordinators’ Partnership.
When will I know if my poster abstract was accepted for presentation?
The lead author will be notified of the Review Committee’s decision by April 1, 2020.
Will I need to be present at the Summit meeting in order for my poster to be displayed?
Yes, (Summit registration information available here.) The major purpose of the poster session is to share ideas and stimulate discussion. Therefore, a poster author (or co-author) is expected to be available by the poster during the display session on May 18th.
Will my abstract (if accepted) be published?
With your permission, your abstract and poster will be published on the Summit’s website after the 2020 meeting takes place.
Who do I contact if I have a question about poster abstract submission?
For questions, contact LaDora Woods at ecz3@cdc.gov.